Investment ThemesDetailed Quotes
Gene Editing
Watchlist
Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1306.439
- +4.687+0.36%
Close Dec 26 16:00 ET
1307.157High1293.069Low
1297.840Open1301.752Pre Close14.87MVolume7Rise63.86P/E (Static)699.94MTurnover--Flatline1.19%Turnover Ratio156.65BMarket Cap3Fall154.37BFloat Cap
Constituent Stocks: 10Top Rising: BLUE+12.71%
Sign in to post a comment
$CRISPR Therapeutics (CRSP.US)$ I wonder if it's cathy that's selling all these premiums
5
The performance of U.S. markets at the year-end and the beginning of a new year, particularly during a presidential inauguration year, often depends on several historical and economic factors. Here’s an overview based on trends and historical precedence:
Year-End Market Trends (“Santa Claus Rally”)
1. Santa Claus Rally:
Historically, U.S. markets often experience a “Santa Claus Rally” during the last week of December through the first two trading days of ...
Year-End Market Trends (“Santa Claus Rally”)
1. Santa Claus Rally:
Historically, U.S. markets often experience a “Santa Claus Rally” during the last week of December through the first two trading days of ...
45
4
26
$Sangamo Therapeutics (SGMO.US)$
Should be interesting to see what we get in up front. It's been given Accelerated Approval by FDA so BLA will be filed next year sometime once we get final patient data. I'm guessing 100 to 200 million up front.
Should be interesting to see what we get in up front. It's been given Accelerated Approval by FDA so BLA will be filed next year sometime once we get final patient data. I'm guessing 100 to 200 million up front.
$CRISPR Therapeutics (CRSP.US)$ It's loading time
1
1
$Sangamo Therapeutics (SGMO.US)$ lets see how it goes. W pattern maybe.
2
$Sangamo Therapeutics (SGMO.US)$ net outflow, rid off weak holders, yet price holding up well. in the watch list for dip picking.
“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...
No comment yet
10baggerbamm : if you get her updates she's been aggressively buying the stock.. and she was a buyer this week.
Kim10 OP 10baggerbamm : interesting to see her trim tesla and buy this all we need now is for cramer to recommend this
10baggerbamm Kim10 OP : that's the problem with Kathy Woods.. she has these grandiose projections on Tesla Optimus 27 trillion in revenue to make every TV camera go her way she gets on Bloomberg and CNBC and Fox Business and then what does she do she dumps Tesla stock she sells palantir stock and she buys ....train wrecks. she's looking for turnarounds so she sells winners and buys short-term problematic fundamentally or technical challenge companies.
Kim10 OP 10baggerbamm : she's here for a good time not a long time who gives a flying fuck abt the shareholders amiright![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
10baggerbamm Kim10 OP : I think the reason for her selling her winners Tesla palantir is she doesn't have the inflows anymore coming in or she has the ability to continuously put money to work I think because of her shit performance the fact that she's lagged so horrifically the S&P 500 money has left her portfolio of funds her basket of funds and this hurts her ability more than anything else so she's forced to sell winners and buy turnarounds with those monies.. if she had the amount of inflows like she had several years ago I don't believe you would see her selling her Tesla's, pltr and companies like that